SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-18-000486
Filing Date
2018-12-24
Accepted
2018-12-21 20:03:26
Documents
67
Period of Report
2018-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gnbt103118form10q.htm 10-Q 902054
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 23234
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 16047
4 EXHIBIT 32 ex32.htm EX-32 4073
  Complete submission text file 0001607062-18-000486.txt   3518024

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE gnbt-20181031.xml EX-101.INS 450248
6 XBRL SCHEMA FILE gnbt-20181031.xsd EX-101.SCH 44887
7 XBRL CALCULATION FILE gnbt-20181031_cal.xml EX-101.CAL 37414
8 XBRL DEFINITION FILE gnbt-20181031_def.xml EX-101.DEF 160605
9 XBRL LABEL FILE gnbt-20181031_lab.xml EX-101.LAB 238083
10 XBRL PRESENTATION FILE gnbt-20181031_pre.xml EX-101.PRE 238771
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-25169 | Film No.: 181251033
SIC: 2834 Pharmaceutical Preparations